Skip to main content

Journals in Immunopathogenesis

    • American Journal of Preventive Medicine

      • ISSN: 0749-3797
      The American Journal of Preventive Medicine is the official journal of the American College of Preventive Medicine and the Association for Prevention Teaching and Research. It publishes articles in the areas of prevention research, teaching, practice and policy. Original research is published on interventions aimed at the prevention of chronic and acute disease and the promotion of individual and community health.Of particular emphasis are papers that address the primary and secondary prevention of important clinical, behavioral and public health issues such as injury and violence, infectious disease, women's health, smoking, sedentary behaviors and physical activity, nutrition, diabetes, obesity, and substance use disorders. Papers also address educational initiatives aimed at improving the ability of health professionals to provide effective clinical prevention and public health services. Papers on health services research pertinent to prevention and public health are also published. The journal also publishes official policy statements from the two co-sponsoring organizations, review articles, media reviews, and editorials. Finally, the journal periodically publishes supplements and special theme issues devoted to areas of current interest to the prevention community.
    • The Journal of Heart and Lung Transplantation

      • ISSN: 1053-2498
      The Journal of Heart and Lung Transplantation (JHLT), the official publication of the International Society for Heart and Lung Transplantation, brings readers cutting-edge clinical, basic, and translational science in the fields of advanced heart and lung disease, cardio-pulmonary transplantation, mechanical and biological support of the failing heart, pulmonary vascular disease (pulmonary arterial hypertension and CTEPH), extracorporeal support of donor organs, and cell replacement therapy.
    • The Lancet

      • ISSN: 0140-6736
      The Lancet is an independent, international general medical journal founded in 1823 by Thomas Wakley. Since its first weekly issue (October 5, 1823), the journal has strived to make science widely available so that medicine can serve, and transform society, and positively impact the lives of people.The Lancet is committed to applying scientific knowledge to improve health and advance human progress. In our weekly issues, and Online First content, we publish some of the best science from the best scientists worldwide, providing an unparalleled global reach and impact on health.
    • Parasitology International

      • ISSN: 1383-5769
      The Official, International Journal of the Japanese Society of ParasitologyParasito... International provides a medium for rapid, carefully reviewed publications in the field of human and animal parasitology. Original papers, rapid communications, and original case reports from all geographical areas and covering all parasitological disciplines, including structure, immunology, cell biology, biochemistry, molecular biology, and systematics, may be submitted. Reviews on recent developments are invited regularly, but suggestions in this respect are welcome. Letters to the Editor commenting on any aspect of the Journal are also welcome.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
    • Clinical Microbiology Newsletter

      • ISSN: 0196-4399
      Clinical Microbiology Newsletter is published four issues per year to provide consistent educational features and to keep pace with advances in the fast-moving field of Clinical Microbiology.Clinica... Microbiology Newsletter aims to provide articles to enable you to streamline procedures and improve results. It publishes reviews on infectious disease pathogens, reports on changes that affect your work, including articles on new diagnostic techniques, regulatory and guideline changes, and challenging diagnostic dogmas, clinical cases focused on diagnostic approaches for both common and uncommon pathogens.The journal publishes three types of articles:Mini-review... Case presentationsSnapsho... articles cover topics including:Minireview... on the epidemiology, pathogenesis, clinical presentation, diagnosis, and treatment of infectious diseases,Practical articles on common and contemporary laboratory techniques,Indispens... updates on important clinical problems that impact the clinical laboratory,Editorial... and opinions on controversial issues in laboratory medicine,Case-based articles focused on diagnostic approaches for infectious pathogens,Snapshots highlighting specific infectious pathogens, therapeutic options, and diagnostic methodologies.Helpfu... tips on improving the laboratory workplace.
    • Veterinary Immunology and Immunopathology

      • ISSN: 0165-2427
      An International Journal of Comparative ImmunologyThe journal reports basic, comparative and clinical immunology as they pertain to the animal species designated here: livestock, poultry, and fish species that are major food animals and companion animals such as cats, dogs, horses and camels, and wildlife species that act as reservoirs for food, companion or human infectious diseases, or as models for human disease.Rodent models of infectious diseases that are of importance in the animal species indicated above,when the disease requires a level of containment that is not readily available for larger animal experimentation (ABSL3), will be considered. Papers on rabbits, lizards, guinea pigs, badgers, armadillos, elephants, antelope, and buffalo will be reviewed if the research advances our fundamental understanding of immunology, or if they act as a reservoir of infectious disease for the primary animal species designated above, or for humans. Manuscripts employing other species will be reviewed if justified as fitting into the categories above.The following topics are appropriate: biology of cells and mechanisms of the immune system, immunochemistry, immunodeficiencies, immunodiagnosis, immunogenetics, immunopathology, immunology of infectious disease and tumors, immunoprophylaxis including vaccine development and delivery, immunological aspects of pregnancy including passive immunity, autoimmuity, neuroimmunology, and transplanatation immunology. Manuscripts that describe new genes and development of tools such as monoclonal antibodies are also of interest when part of a larger biological study. Studies employing extracts or constituents (plant extracts, feed additives or microbiome) must be sufficiently defined to be reproduced in other laboratories and also provide evidence for possible mechanisms and not simply show an effect on the immune system.Ideas and suggestions for Special Issues are also welcome. These may focus on a planned conference/symposium for which a selection of the best papers could be published together (after peer review). Alternatively, they could consist of a group of invited papers which together present an up-to-date overview on an important immunological topic.
    • Antiviral Research

      • ISSN: 0166-3542
      Antiviral Research aims to publish manuscripts in the field of prevention and treatment of viral diseases in humans and vertebrate animals, and encourages authors to the submit manuscripts describing the activity of well-defined chemical compounds for the treatment of viral diseases. The journal is an Official Publication of the International Society for Antiviral Research. The types of papers published in Antiviral Research includes original research reports, short communications, commentaries and invited review* articles on the control of viral infections in humans. The journal’s scope encompasses:antivira... drugs, antibodies and host-response modifiers, including their synthesis, in vitro and in vivo testing and mechanisms of action.identificatio... and validation of new drug targets;laboratory animal models of viral diseases for antiviral efficacy testing;evolution of drug-resistant viruses and the development of effective counter measures;pathogenesi... of viral diseases and mechanisms of viral evasion of host immune responses;assessment... of drug safety;new or improved vaccines against viral infections of humans; the prevention and treatment of viral diseases of vertebrate animals, and reports of the testing of veterinary vaccines in the target animal species. All papers must include a sufficiently detailed description of methods to permit other investigators to replicate the experiments. Authors reporting the antiviral effect of a novel small-molecule drug must reveal its chemical structure. Claims of in vitro or in vivo efficacy of a drug or vaccine must be supported by appropriate statistical analysis that must be clearly described in the manuscript.Antiviral Research journal does not publish reports on viral diseases of plants or of insects, crustaceans or other invertebrates. Studies of viral diseases of livestock and companion animals must be clearly related to the development of realistic therapies. Papers on veterinary vaccines should report findings in the target animal species.We discourage the submission of manuscripts reporting the antiviral activity of unpurified natural products, or of partially purified substances of natural origin for which a mechanism of action has not been determined. Manuscripts claiming an antiviral effect of homeopathic products or other highly diluted preparations, or which fail to clearly identify the biological ingredient or molecule responsible for the antiviral activity of an experimental therapy, will not be considered for publication. Articles describing antiseptics with broad-spectrum antimicrobial activity will not be accepted. We discourage the submission of in silico docking studies or other computer-based predictions of antiviral activity that are not supported by data from biological assays. Citations of reports that have not undergone peer review must include the note "[not peer-reviewed]."ISAR members Authors who are ISAR members are encouraged to contact ISAR after their paper has been accepted for publication in order to benefit from their published work being highlighted in ISAR postings on their social media platforms (further details on this will be given in the AVR acceptance letter). *Antiviral Research journal has started a new initiative to publish at least two thematic special issues per year, containing invited reviews in addition to the ad hoc invitations to experts in the areas within the scope of the journal.
    • Biochimica et Biophysica Acta: Molecular Basis of Disease

      • ISSN: 0925-4439
      BBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease.Manuscripts should emphasize the underlying molecular mechanisms of human disease pathways and provide significant advances to the understanding and/or treatment of these disorders.Studies in model organisms or systems are strongly recommended in order to validate mechanistic insights. Topics of interest include, but are not limited toAgingCancerCardiov... diseasesCell death–related diseasesGenetic diseasesGenetic and epigenetic regulation in diseasesImmunologica... diseasesInflammatory diseasesMetabolic diseasesMitochondria... diseasesMuscular diseasesNeurological diseasesThe non-preferred topics for BBADIS includeNon-coding RNAsResearch on non-coding RNAs (microRNAs, lncRNAs, circRNAs, etc.) will be considered only if it provides significantly novel insights into disease mechanisms.Single Cell Line StudiesStudies involving single cell lines will be considered only if they present significantly novel findings.Computation... (in Silico) StudiesPurely computational works (e.g., Mendelian randomization, molecular docking, molecular dynamics) will generally be declined unless they provide novel insights into disease mechanisms.Disease BiomarkersResearch on disease biomarkers will be considered only if it relates to the explanation of disease mechanisms.Descripti... or Correlative StudiesDescriptive or correlative studies (e.g., up/down regulation of gene products, -omics studies without follow-up experiments) will be declined unless they provide mechanistic insights.Natural Products and Traditional MedicineWork on natural products, extracts, and traditional medicine will be considered only if single biochemical components are characterized and tested.Clinical Studies and Case ReportsClinical studies or case reports without mechanistic insights are outside the scope of the journal.Hypothesis ArticlesSubmissions based solely on hypotheses will not be considered.Comparati... Genomics StudiesComparative genomics studies (e.g., GWAS) will only be considered if they provide specific insights into the structural and/or functional properties of individual genes.Incremental WorkResearch that offers incremental advancements without significant novelty or impact will generally be declined.
    • Immunology Letters

      • ISSN: 0165-2478
      Published by Elsevier as the official journal of the European Federation of Immunological Societies (EFIS), a member of the International Union of Immunological SocietiesImmunology Letters provides a vehicle for the speedy publication of experimental papers, (mini)Reviews and Letters to the Editor addressing all aspects of molecular, cellular, and clinical immunology. As the official journal of the European Federation of Immunological Societies (EFIS), Immunology Letters supports international consortia of experts. The journal welcomes collaborative contributions dedicated to the state-of-the-art of immunology topics, as well as commentaries on those topics.Preference is given to papers of immediate importance to other investigators. Therefore, the essential criteria for publication are clarity, experimental soundness and novelty. Results contradictory to current accepted thinking or ideas divergent from actual dogmas are considered for publication provided they are based on solid experimental findings. Scientific correspondence to the Editor-in-Chief related to the published papers may also be accepted provided they are short and scientifically relevant to the papers mentioned, in order to provide a continuing forum for discussion.
    • Journal of Autoimmunity

      • ISSN: 0896-8411
      The Journal of Autoimmunity is a parent journal of the Journal of Translational Autoimmunity . The Journal of Autoimmunity publishes papers related to the diverse aspects of autoimmunity: the mechanism of self-recognition, regulation of autoimmune responses, experimental autoimmune diseases, diagnostic autoantibody tests, and the epidemiology, pathophysiology, and treatment of autoimmune diseases. Special, but not exclusive, attention will be given to papers dealing with genetic, molecular biology, and cellular aspects of the discipline.Research Areas Include:• Underlying mechanisms of autoimmunity • Immunologic • Molecular • Cellular • Genetic • VirologicAreas of Clinical Interest:• Rheumatology • Dermatology • Endocrinology • Nephrology • Haematology • Immunopharmacology